0 followers
Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust... Read more
Steven Altschuler
ARS Pharmaceuticals
1 follower
Vaxcyte
2 followers
Neogene Therapeutics
2 followers
Aura Biosciences
1 follower
Cardurion Pharmaceuticals
1 follower
Aviceda Therapeutics
1 follower
Foresight Diagnostics
1 follower
Applied Therapeutics
1 follower
Anthos Therapeutics
1 follower
Amgen
235 followers
Nuvalent
1 follower
Explore companies